MARKER THERAPEUTICS, INC. Cash, Period Increase (Decrease)
MARKER THERAPEUTICS, INC. (MRKR) reported Cash, Period Increase (Decrease) of -$4.04 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-10.
Discontinued › Notes
us-gaap:CashPeriodIncreaseDecrease · last filed 2019-05-10
- MARKER THERAPEUTICS, INC. cash, period increase (decrease) for the quarter ending 2019-03-31 was -$4.04M.
- MARKER THERAPEUTICS, INC. cash, period increase (decrease) for the quarter ending 2018-12-31 was $57.45M.
- MARKER THERAPEUTICS, INC. cash, period increase (decrease) for the quarter ending 2018-09-30 was -$3.49M.
- MARKER THERAPEUTICS, INC. cash, period increase (decrease) for the quarter ending 2018-06-30 was $4.98M, a 23.46% increase year-over-year.
- MARKER THERAPEUTICS, INC. cash, period increase (decrease) for fiscal 2018 was $56.62M.
- MARKER THERAPEUTICS, INC. cash, period increase (decrease) for fiscal 2017 was -$2.72M, a 313.54% decline from fiscal 2016.
- MARKER THERAPEUTICS, INC. cash, period increase (decrease) for fiscal 2016 was $1.27M, a 80.19% decline from fiscal 2015.
- MARKER THERAPEUTICS, INC. cash, period increase (decrease) for fiscal 2015 was $6.43M, a 6792.64% increase from fiscal 2014.
| Period end | Cash, Period Increase (Decrease) 3 month | Cash, Period Increase (Decrease) 3 month as first filed | Cash, Period Increase (Decrease) 6 month | Cash, Period Increase (Decrease) 9 month | Cash, Period Increase (Decrease) 12 month | Cash, Period Increase (Decrease) 143 month | Cash, Period Increase (Decrease) 146 month | Cash, Period Increase (Decrease) 149 month | Cash, Period Increase (Decrease) 152 month | Cash, Period Increase (Decrease) 155 month | Cash, Period Increase (Decrease) 158 month | Cash, Period Increase (Decrease) 164 month | Cash, Period Increase (Decrease) 167 month | Cash, Period Increase (Decrease) 170 month | Cash, Period Increase (Decrease) 173 month | Cash, Period Increase (Decrease) 173 month as first filed | Cash, Period Increase (Decrease) 179 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-03-31 | -$4.04M 10-Q · filed 2019-05-10 | $53.41M derived: sum of 2 quarters · filed 2019-05-10 | $49.92M derived: sum of 3 quarters · filed 2019-05-10 | $54.91M derived: sum of 4 quarters · filed 2019-05-10 | |||||||||||||
| 2018-12-31 | $57.45M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $53.96M derived: sum of 2 quarters · filed 2019-03-15 | $58.95M derived: sum of 3 quarters · filed 2019-03-15 | $56.62M 10-K · filed 2019-03-15 | |||||||||||||
| 2018-09-30 | -$3.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $1.49M derived: sum of 2 quarters · filed 2018-11-13 | -$835.02K 10-Q · filed 2018-11-13 | -$3.31M derived: sum of 4 quarters · filed 2019-05-10 | |||||||||||||
| 2018-06-30 | $4.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $2.65M 10-Q · filed 2018-08-09 | $175.23K derived: sum of 3 quarters · filed 2019-05-10 | -$2.18M derived: sum of 4 quarters · filed 2019-05-10 | |||||||||||||
| 2018-03-31 | -$2.33M 10-Q · filed 2019-05-10 | -$4.81M derived: sum of 2 quarters · filed 2019-05-10 | -$7.16M derived: sum of 3 quarters · filed 2019-05-10 | -$3.13M derived: sum of 4 quarters · filed 2019-05-10 | |||||||||||||
| 2017-12-31 | -$2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | -$4.83M derived: sum of 2 quarters · filed 2019-03-15 | -$798.28K derived: sum of 3 quarters · filed 2019-03-15 | -$2.72M 10-K · filed 2019-03-15 | |||||||||||||
| 2017-09-30 | -$2.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $1.68M derived: sum of 2 quarters · filed 2018-11-13 | -$243.51K 10-Q · filed 2018-11-13 | -$1.98M derived: sum of 4 quarters · filed 2018-11-13 | |||||||||||||
| 2017-06-30 | $4.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $2.11M 10-Q · filed 2018-08-09 | $375.84K derived: sum of 3 quarters · filed 2018-08-09 | $6.19M derived: sum of 4 quarters · filed 2018-08-09 | |||||||||||||
| 2017-03-31 | -$1.92M 10-Q · filed 2018-05-15 | -$3.66M derived: sum of 2 quarters · filed 2018-05-15 | $2.16M derived: sum of 3 quarters · filed 2018-05-15 | $205.76K derived: sum of 4 quarters · filed 2018-05-15 | |||||||||||||
| 2016-12-31 | -$1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23 | $4.08M derived: sum of 2 quarters · filed 2018-03-23 | $2.13M derived: sum of 3 quarters · filed 2018-03-23 | $1.27M 10-K · filed 2018-03-23 | |||||||||||||
| 2016-09-30 | $5.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $3.86M derived: sum of 2 quarters · filed 2017-11-14 | $3.01M 10-Q · filed 2017-11-14 | $3.50M derived: sum of 4 quarters · filed 2017-11-14 | |||||||||||||
| 2016-06-30 | -$1.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$2.81M 10-Q · filed 2017-08-07 | -$2.32M derived: sum of 3 quarters · filed 2017-08-07 | $662.34K derived: sum of 4 quarters · filed 2017-08-07 | |||||||||||||
| 2016-03-31 | -$854.76K 10-Q · filed 2017-05-05 | -$365.21K derived: sum of 2 quarters · filed 2017-05-05 | $2.62M derived: sum of 3 quarters · filed 2017-05-05 | $4.27M derived: sum of 4 quarters · filed 2017-05-05 | |||||||||||||
| 2015-12-31 | $489.55K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $3.47M derived: sum of 2 quarters · filed 2017-03-14 | $5.12M derived: sum of 3 quarters · filed 2017-03-14 | $6.43M 10-K · filed 2017-03-14 | |||||||||||||
| 2015-09-30 | $2.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $4.63M derived: sum of 2 quarters · filed 2016-11-04 | $5.95M 10-Q · filed 2016-11-04 | $5.47M derived: sum of 4 quarters · filed 2016-11-04 | |||||||||||||
| 2015-06-30 | $1.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $2.96M 10-Q · filed 2016-08-15 | $2.49M derived: sum of 3 quarters · filed 2016-08-15 | $3.08M derived: sum of 4 quarters · filed 2016-08-15 | |||||||||||||
| 2015-03-31 | $1.31M 10-Q · filed 2016-05-16 | $839.86K derived: sum of 2 quarters · filed 2016-05-16 | $1.43M derived: sum of 3 quarters · filed 2016-05-16 | $1.36M derived: sum of 4 quarters · filed 2016-05-16 | |||||||||||||
| 2014-12-31 | -$471.70K derived: 10-K 12 month − 10-Q/A 9 month · filed 2016-04-14 | $121.30K derived: sum of 2 quarters · filed 2016-04-14 | $48.31K derived: sum of 3 quarters · filed 2016-04-14 | $93.36K 10-K · filed 2016-04-14 | |||||||||||||
| 2014-09-30 | $593.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2016-04-14 | $520.01K derived: sum of 2 quarters · filed 2016-04-14 | $565.06K 10-Q/A · filed 2016-04-14 | $608.71K derived: sum of 4 quarters · filed 2016-04-14 | |||||||||||||
| 2014-06-30 | -$72.99K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2016-04-14 | -$27.94K 10-Q/A · filed 2016-04-14 | $15.71K derived: sum of 3 quarters · filed 2016-04-14 | -$24.53K derived: sum of 4 quarters · filed 2016-04-14 | $20.65K 10-Q · filed 2014-08-18 | ||||||||||||
| 2014-03-31 | $45.05K 10-Q/A · filed 2016-04-14 | $88.70K derived: sum of 2 quarters · filed 2016-04-14 | $48.46K derived: sum of 3 quarters · filed 2016-04-14 | $89.20K derived: sum of 4 quarters · filed 2016-04-14 | |||||||||||||
| 2013-12-31 | $43.66K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15 | $3.41K derived: sum of 2 quarters · filed 2015-04-15 | $44.15K derived: sum of 3 quarters · filed 2015-04-15 | $14.75K 10-K/A · filed 2014-04-17 | $93.64K 10-Q/A · filed 2014-05-21 | $48.59K 10-K/A · filed 2014-04-17 | |||||||||||
| 2013-09-30 | -$40.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-19 | $497.00 derived: sum of 2 quarters · filed 2014-11-19 | -$28.91K 10-Q · filed 2014-11-19 | $4.93K 10-Q · filed 2013-11-19 | |||||||||||||
| 2013-06-30 | $40.74K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2014-08-18 | $11.34K 10-Q · filed 2014-08-18 | $45.18K 10-Q · filed 2013-08-19 | ||||||||||||||
| 2013-03-31 | -$29.40K 10-Q/A · filed 2014-05-21 | -$46.24K 10-Q · filed 2013-05-21 | $4.44K 10-Q/A · filed 2013-08-19 | ||||||||||||||
| 2012-12-31 | -$216.40K 10-K/A · filed 2014-04-17 | ||||||||||||||||
| 2012-09-30 | -$8.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-19 | -$20.02K derived: sum of 2 quarters · filed 2013-11-19 | -$246.51K 10-Q · filed 2013-11-19 | -$31.05K derived: sum of 4 quarters · filed 2013-11-19 | $3.73K 10-Q · filed 2012-11-19 | ||||||||||||
| 2012-06-30 | -$11.74K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-08-19 | -$238.22K 10-Q · filed 2013-08-19 | -$22.76K derived: sum of 3 quarters · filed 2013-08-19 | -$2.47K derived: sum of 4 quarters · filed 2013-08-19 | $12.01K 10-Q/A · filed 2012-09-12 | ||||||||||||
| 2012-03-31 | -$226.48K 10-Q/A · filed 2013-08-19 | -$11.02K derived: sum of 2 quarters · filed 2013-08-19 | $9.27K derived: sum of 3 quarters · filed 2013-08-19 | -$13.78K derived: sum of 4 quarters · filed 2013-08-19 | $23.75K 10-Q · filed 2012-05-21 | ||||||||||||
| 2011-12-31 | $215.46K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | $235.75K derived: sum of 2 quarters · filed 2012-11-19 | $212.70K derived: sum of 3 quarters · filed 2012-11-19 | $226.72K 10-K · filed 2012-04-16 | $250.23K 10-K · filed 2012-04-16 | ||||||||||||
| 2011-09-30 | $20.29K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-19 | -$2.76K derived: sum of 2 quarters · filed 2012-11-19 | $11.26K 10-Q · filed 2012-11-19 | -$109.97K derived: sum of 4 quarters · filed 2012-11-19 | $34.77K 10-Q · filed 2011-11-21 | ||||||||||||
| 2011-06-30 | -$23.05K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-12 | -$9.03K 10-Q/A · filed 2012-09-12 | -$130.26K derived: sum of 3 quarters · filed 2012-09-12 | -$435.77K derived: sum of 4 quarters · filed 2012-09-12 | $14.48K 10-Q · filed 2011-08-22 | ||||||||||||
| 2011-03-31 | $14.02K 10-Q · filed 2012-05-21 | -$107.21K derived: sum of 2 quarters · filed 2012-05-21 | -$412.73K derived: sum of 3 quarters · filed 2012-05-21 | ||||||||||||||
| 2010-12-31 | -$121.22K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | -$426.74K derived: sum of 2 quarters · filed 2012-04-16 | -$117.92K 10-K · filed 2012-04-16 | ||||||||||||||
| 2010-09-30 | -$305.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-21 | $3.31K 10-Q · filed 2011-11-21 | |||||||||||||||
| 2010-06-30 | $308.83K 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |